Selective growth-inhibitory, cell-cycle deregulatory and apoptotic response of apigenin in normal versus human prostate carcinoma cells.

Agents that are capable of inducing selective apoptosis of cancer cells are receiving considerable attention in developing novel cancer-preventive approaches. In the present study, employing normal human prostate epithelial cells (NHPE), virally transformed normal human prostate epithelial cells (PZ-HPV-7), and human prostate adenocarcinoma (CA-HPV-10) cells, we evaluated the growth-inhibitory effects of apigenin, a flavonoid abundantly present in fruits and vegetables. Apigenin treatment to NHPE and PZ-HPV-7 resulted in almost similar growth inhibitory responses of low magnitude. In sharp contrast, apigenin treatment resulted in a significant decrease in cell viability of CA-HPV-10 cells. Similar selective growth inhibitory effects were also observed for human epidermoid carcinoma A431 cells compared to normal human epidermal keratinocytes. Apigenin treatment resulted in significant apoptosis of CA-HPV-10 cells as evident from (i) DNA ladder assay, (ii) fluorescence microscopy, and (iii) TUNEL assay, whereas the NHPE and PZ-HPV-7 cells did not undergo apoptosis but showed exclusive necrotic staining only at a high dose of 40 microM. Apigenin (1-10 microM) also resulted in a dose-dependent G2-M phase cell cycle arrest of CA-HPV-10 cells but not of PZ-HPV-7 cells. The growth-inhibitory and apoptotic potential of apigenin was also observed in a variety of prostate carcinoma cells representing different stage and androgen responsiveness. Apigenin may be developed as a promising chemopreventive and/or chemotherapeutic agent against prostate cancer.

[1]  M. Kuo,et al.  Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes. , 1995, Biochemical and biophysical research communications.

[2]  H. Adlercreutz,et al.  Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. , 1997, Cancer research.

[3]  L. Iversen,et al.  Effects of naturally-occurring flavonoids and biflavonoids on epidermal cyclooxygenase and lipoxygenase from guinea-pigs. , 1998, Prostaglandins, leukotrienes, and essential fatty acids.

[4]  M. Kobori,et al.  Flavonoids Inhibit Cell Growth and Induce Apoptosis in B16 Melanoma 4A5 Cells , 2000, Bioscience, biotechnology, and biochemistry.

[5]  A. Giuliano,et al.  Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells. , 2001, Anticancer research.

[6]  C. F. Chen,et al.  Suppression of inducible cyclooxygenase and inducible nitric oxide synthase by apigenin and related flavonoids in mouse macrophages. , 1999, Carcinogenesis.

[7]  J. Stanford,et al.  Fruit and vegetable intakes and prostate cancer risk. , 2000, Journal of the National Cancer Institute.

[8]  S. Gupta,et al.  Prostate cancer chemoprevention by green tea. , 1999, Seminars in urologic oncology.

[9]  A. V. Van Herle,et al.  Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). , 1999, Anticancer research.

[10]  Carrita A. Hightower,et al.  Flavonoids Suppress Androgen-Independent Human Prostate Tumor Proliferation , 2000, Nutrition and cancer.

[11]  L. Tye,et al.  Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. , 1990, Cancer research.

[12]  J. L. Hess,et al.  Antioxidants in Higher Plants , 1993 .

[13]  P. Hollman,et al.  Health effects and bioavailability of dietary flavonols. , 1999, Free radical research.

[14]  C. Chaumontet,et al.  Flavonoids (apigenin, tangeretin) counteract tumor promoter-induced inhibition of intercellular communication of rat liver epithelial cells. , 1997, Cancer letters.

[15]  R. Gaynor,et al.  Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer. , 2001, The Journal of clinical investigation.

[16]  E. Bresnick,et al.  Anti-mutagenesis and anti-promotion by apigenin, robinetin and indole-3-carbinol. , 1986, Carcinogenesis.

[17]  A. Porter,et al.  Target to apoptosis: A hopeful weapon for prostate cancer , 1997, The Prostate.

[18]  J. Pelling,et al.  Induction of p21/WAF1 and G1 cell‐cycle arrest by the chemopreventive agent apigenin , 1997, Molecular carcinogenesis.

[19]  P. Pour,et al.  Inhibition of ultraviolet light induced skin carcinogenesis in SKH-1 mice by apigenin, a plant flavonoid. , 1997, Anticancer research.

[20]  K. Griffiths,et al.  Diet and Its Preventive Role in Prostatic Disease , 1999, European Urology.

[21]  R. Agarwal,et al.  Green tea constituent epigallocatechin-3-gallate and induction of apoptosis and cell cycle arrest in human carcinoma cells. , 1997, Journal of the National Cancer Institute.

[22]  J. Pelling,et al.  Cell‐Cycle Arrest at G2/M and Growth Inhibition by Apigenin in Human Colon Carcinoma Cell Lines , 2000, Molecular carcinogenesis.